CAD drives Angiotensin II-induced vascular smooth muscle cell activation via upregulation of pyrimidine biosynthesis and rRNA synthesis
Life Sciences · 2026-09 · 401 · 124530
DOI: 10.1016/j.lfs.2026.124530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-09. Verfasst von Mun-Ju Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Kyungpook National University, Daegu, 41566, South Korea. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Angiotensin II, Pyrimidines, Myocytes, Smooth Muscle. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Calgary Arts Development, Korea Ministry of Education, National Research Foundation of Korea.
Abstract (Originalsprache)
AIMS: Vascular smooth muscle cell (VSMC) phenotypic switching is a hallmark of vascular remodeling in diseases such as restenosis and atherosclerosis. Although Angiotensin II (Ang II) promotes VSMC proliferation and migration through various signaling pathways, the role of nucleotide metabolism remains poorly understood. This study investigates the functional significance of CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase), a rate-limiting enzyme in de novo pyrimidine biosynthesis, in Ang II-induced VSMC activation and pathological vascular remodeling. MATERIALS AND METHODS: Primary VSMCs were stimulated with Ang II to induce phenotypic switching. A mouse carotid artery ligation model was used to study neointimal hyperplasia in vivo. VSMC proliferation and migration were assessed via EdU incorporation and Transwell assays, respectively. The functional role of CAD expression was interrogated through pharmacological inhibition and gene silencing. Molecular mechanisms, including ribosomal RNA (rRNA) synthesis and protein translation, were analyzed using Western blotting and qPCR. KEY FINDINGS: Ang II stimulation and vascular injury significantly increased CAD expression and phosphorylation. This activation enhanced rRNA synthesis and translation of remodeling-associated proteins, including intercellular adhesion molecule-1 (ICAM-1) and matrix metalloproteinase-9 (MMP-9). Uridine supplementation rescued phenotypic defects caused by CAD silencing, confirming that pyrimidine biosynthesis sustains the pathological VSMC phenotype. Furthermore, CAD inhibition attenuated Ang II-induced VSMC proliferation and migration in vitro and reduced neointimal hyperplasia in vivo. SIGNIFICANCE: Our findings identify nucleotide metabolism as a central determinant of VSMC pathology. By linking biosynthetic signaling to translational control, CAD represents a promising therapeutic target for proliferative vascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, Kyungpook National University, Daegu, 41566, South Korea.
- Department of Biomedical Science, Kyungpook National University, Daegu, 41566, South Korea; Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, 41566, South Korea; Department of Internal Me…
- Departmentof Internal Medicine, CHA Gumi Medical Center, CHA University, Gumi, 39295, South Korea. Electronic address: ghjeong93@chamc.co.kr.
- Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, 41566, South Korea. Electronic address: jkbyun@knu.ac.kr.
- Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, 41566, South Korea; Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chi…
Förderung
- Calgary Arts Development
- Korea Ministry of Education
- National Research Foundation of Korea
- Korea Ministry of Science and ICT
Zitieren
APA
Park, M. J., Kim, D., Park, K. G., Jeong, G. H., Byun, J. K., & Choi, Y. K. (2026). CAD drives Angiotensin II-induced vascular smooth muscle cell activation via upregulation of pyrimidine biosynthesis and rRNA synthesis. Life Sciences, 401, 124530. https://doi.org/10.1016/j.lfs.2026.124530
Vancouver
Park MJ, Kim D, Park KG, Jeong GH, Byun JK, Choi YK. CAD drives Angiotensin II-induced vascular smooth muscle cell activation via upregulation of pyrimidine biosynthesis and rRNA synthesis. Life Sciences. 2026;401:124530. doi:10.1016/j.lfs.2026.124530
BibTeX
@article{Park2026,
author = {Park, Mun-Ju and Kim, Daehoon and Park, Keun-Gyu and Jeong, Gui-Hwa and Byun, Jun-Kyu and Choi, Yeon-Kyung},
title = {CAD drives Angiotensin II-induced vascular smooth muscle cell activation via upregulation of pyrimidine biosynthesis and rRNA synthesis},
journal = {Life Sciences},
year = {2026},
volume = {401},
pages = {124530},
doi = {10.1016/j.lfs.2026.124530}
}
EUVIMED